10 / 33
Olaparib met the primary endpoint of improving PFS in the OVERALL
study population
Ledermann J et al. N Engl J Med 2012
|
|
10 / 33
10 / 33
Olaparib met the primary endpoint of improving PFS in the OVERALL
study population
Ledermann J et al. N Engl J Med 2012